Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART621 in Rheumatoid Arthritis
NCT00928317Phase 2Terminated
- Sponsor
- Arana Therapeutics
- Start
- Apr 2009
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of placulumab in rheumatoid arthritis (RA), sponsored by Arana Therapeutics. Started Apr 2009; status: terminated.
02
Drugs
placulumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00928317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928317.